A Study to Evaluate the Safety, Reactogenicity, and Effectiveness of mRNA-1273 Vaccine in Adolescents 12 to <18 Years Old to Prevent COVID-19
Clinical trial NCT04649151 · COMPLETED
Trial details
- NCT number
- NCT04649151
- Sponsor
- ModernaTX, Inc.
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-09
- Primary completion
- 2024-06-14
- Enrollment
- 4328
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.